Malaria continues to be a global health burden, threatening over 40% of the world’s population. Drug resistance in Plasmodium falciparum, the etiological agent of the majority of human malaria cases, is compromising elimination efforts. New approaches to treating drug-resistant malaria benefit from defining resistance liabilities of known antimalarial agents and compounds in development and defining genetic changes that mediate loss of parasite susceptibility. Here, we present protocols for in vitro selection of drug-resistant parasites and for site-directed gene editing of candidate resistance mediators to test for causality.
CITATION STYLE
Ng, C. L., & Fidock, D. A. (2019). Plasmodium falciparum in vitro drug resistance selections and gene editing. In Methods in Molecular Biology (Vol. 2013, pp. 123–140). Humana Press Inc. https://doi.org/10.1007/978-1-4939-9550-9_9
Mendeley helps you to discover research relevant for your work.